RMR Wealth Builders’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,346
Closed -$272K 195
2022
Q3
$272K Buy
3,346
+1
+0% +$90 0.07% 150
2022
Q2
$300K Buy
3,345
+1
+0% +$101 0.07% 141
2022
Q1
$371K Sell
3,344
-51
-2% -$5.39K 0.08% 141
2021
Q4
$353K Buy
+3,395
New +$393K 0.1% 85
2021
Q2
Sell
-2,363
Closed -$279K 475
2021
Q1
$279K Buy
2,363
+1,061
+81% +$124K 0.07% 143
2020
Q4
$153K Sell
1,302
-976
-43% -$107K 0.08% 173
2020
Q3
$237K Buy
2,278
+2,249
+7,755% +$226K 0.06% 179
2020
Q2
$3K Buy
+29
New +$2.78K ﹤0.01% 402
2019
Q4
$3K Buy
+29
New +$3.18K ﹤0.01% 386

Other funds holding MDT

RMR Wealth Builders's MDT Position: Q4 2022 in Review

RMR Wealth Builders sold out of Medtronic (MDT) in Q4 2022, closing a stake of 3,346 shares — an estimated $272K sold.

RMR Wealth Builders first reported a position in MDT in Q4 2019 and held it in 9 quarters. The position peaked at $371K in Q1 2022. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • RMR Wealth Builders reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • RMR Wealth Builders sold 3,346 Medtronic shares in Q4 2022, an estimated $272K.
  • RMR Wealth Builders first reported a position in Medtronic in Q4 2019 and held it in 9 quarters.
  • RMR Wealth Builders's Medtronic position peaked at $371K in Q1 2022.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on RMR Wealth Builders's 13F filing for Q4 2022, filed 2 Feb 2023.